{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:18:34Z","timestamp":1783124314067,"version":"3.54.6"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018748","name":"Healthy Aging Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002836","name":"Chang Gung University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 110-2320-B-182-003-MY3"],"award-info":[{"award-number":["NSTC 110-2320-B-182-003-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neuint.2026.106186","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:06:26Z","timestamp":1778861186000},"page":"106186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lrp10 insufficiency upregulates mRNA and protein of neurotoxic \u03b1-synuclein and causes degeneration of substantia nigra dopaminergic neurons in heterozygous or homozygous Lrp10 knockout mice"],"prefix":"10.1016","volume":"197","author":[{"given":"Hung-Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chi","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu-Hsueh","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Ju","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Rung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2026.106186_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11910-022-01207-5","article-title":"Neurodegeneration and neuroinflammation in Parkinson's disease: a self-sustained loop","volume":"22","author":"Arena","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.neuint.2026.106186_bib2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/neurolint16030037","article-title":"Oxidative stress and neurodegeneration: insights and therapeutic strategies for Parkinson's disease\u201d","volume":"16","author":"Bej","year":"2024","journal-title":"Neurol. Int."},{"key":"10.1016\/j.neuint.2026.106186_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578180","article-title":"Microglia mediated neuroinflammation in neurodegenerative diseases: a review on the cell signaling pathways involved in microglial activation","volume":"383","author":"Biswas","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuint.2026.106186_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00418-008-0436-5","article-title":"Intracellular trafficking of LRP9 is dependent on two acidic cluster\/dileucine motifs\u201d","volume":"130","author":"Boucher","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.neuint.2026.106186_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1326-7-31","article-title":"LDLR-related protein 10 (LRP10) regulates amyloid precursor protein trafficking and processing: evidence for a role in Alzheimer's disease","volume":"7","author":"Brodeur","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2026.106186_bib6","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/brain\/awad150","article-title":"Advances in understanding the function of alpha-synuclein: implications for Parkinson's disease","volume":"146","author":"Calabresi","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2026.106186_bib7","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.neuron.2023.03.021","article-title":"Cognitive heterogeneity in Parkinson's disease: a mechanistic view","volume":"111","author":"Carceles-Cordon","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2026.106186_bib8","doi-asserted-by":"crossref","first-page":"43277","DOI":"10.1074\/jbc.M107013200","article-title":"Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells","volume":"276","author":"Castro","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106186_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104855","article-title":"Neuronal circuitry for recognition memory of object and place in rodent models","volume":"141","author":"Chao","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuint.2026.106186_bib10","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/cdd.2012.42","article-title":"(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD","volume":"19","author":"Chen","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuint.2026.106186_bib11","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mds.27693","article-title":"LRP10 in autosomal-dominant Parkinson's disease","volume":"34","author":"Chen","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2026.106186_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq6324","article-title":"Intronic enhancers of the human SNCA gene predominantly regulate its expression in brain in vivo\u201d","volume":"8","author":"Cheng","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuint.2026.106186_bib13","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/mds.21007","article-title":"Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients","volume":"21","author":"Chiba-Falek","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2026.106186_bib14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/s41419-020-03228-9","article-title":"(D620N) VPS35 causes the impairment of Wnt\/\u03b2-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model\u201d","volume":"11","author":"Chiu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuint.2026.106186_bib15","article-title":"Absence of Rab39b-induced macroautophagy impairment increases neurotoxic \u03b1-synuclein and causes degeneration of substantia nigra dopaminergic neurons in mouse model of X-linked Parkinson's disease\u201d","volume":"337","author":"Chiu","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2026.106186_bib16","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.3390\/ijms25147952","article-title":"Targeting mitochondrial dysfunction and reactive oxygen species for neurodegenerative disease treatment","volume":"25","author":"Choi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2026.106186_bib17","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1016\/j.febslet.2007.08.065","article-title":"Divergent effect of proteasome inhibition on interleukin-1beta and tumor necrosis factor alpha signaling in human astroglial cells","volume":"581","author":"Choi","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2026.106186_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242317027","article-title":"Involvement of mitochondria in Parkinson's disease","volume":"24","author":"Choong","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2026.106186_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fnins.2019.00560","article-title":"Linking the endoplasmic reticulum to Parkinson's disease and alpha-synucleinopathy","volume":"13","author":"Colla","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2026.106186_bib20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","article-title":"Mechanisms of BCL-2 family proteins in mitochondrial apoptosis","volume":"24","author":"Czabotar","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuint.2026.106186_bib21","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.3390\/cells9112495","article-title":"The endoplasmic reticulum stress\/unfolded protein response and their contributions to Parkinson's disease physiopathology\u201d","volume":"9","author":"da Costa","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neuint.2026.106186_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.neuint.2026.106186_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-016-0079-2","article-title":"Direct \u03b1-synuclein promoter transactivation by the tumor suppressor p53","volume":"11","author":"Duplan","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2026.106186_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuint.2026.106186_bib25","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.3390\/ijms21176127","article-title":"Endoplasmic reticulum stress and unfolded protein response in neurodegenerative diseases","volume":"21","author":"Ghemrawi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2026.106186_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.0711053105","article-title":"The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease","volume":"105","author":"Gorbatyuk","year":"2008","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2026.106186_bib27","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/nar\/gkn084","article-title":"Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease","volume":"36","author":"Grundemann","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuint.2026.106186_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2017.04.004","article-title":"Deregulation of \u03b1-synuclein in Parkinson's disease: insight from epigenetic structure and transcriptional regulation of SNCA","volume":"154","author":"Guhathakurta","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2026.106186_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-023-00624-5","article-title":"Sex specific molecular networks and key drivers of Alzheimer's disease","volume":"18","author":"Guo","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2026.106186_bib30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/pharmrev.123.001111","article-title":"Post-translational modifications of \u03b1-synuclein, their therapeutic potential and crosstalk in health and neurodegenerative diseases","volume":"76","author":"Hassanzadeh","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2026.106186_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2026.106186_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuint.2026.106186_bib33","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.ajpath.2015.03.009","article-title":"Multiple mechanisms of unfolded protein response-induced cell death","volume":"185","author":"Hiramatsu","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2026.106186_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12974-015-0332-6","article-title":"Systemic inflammation and microglial activation: systematic review of animal experiments","volume":"12","author":"Hoogland","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2026.106186_bib35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.expneurol.2015.10.010","article-title":"JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease","volume":"277","author":"Huang","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2026.106186_bib36","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.celrep.2018.01.089","article-title":"Pharmacological inhibition of necroptosis protects from dopaminergic neuronal cell death in Parkinson's disease models","volume":"22","author":"Iannielli","year":"2018","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.neuint.2026.106186_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/genes13030471","article-title":"Monogenic Parkinson's disease: genotype, phenotype, pathophysiology, and genetic testing","volume":"13","author":"Jia","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.neuint.2026.106186_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/NRR.NRR-D-23-01195","article-title":"The autophagy-lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson's disease","volume":"20","author":"Jiao","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuint.2026.106186_bib39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mds.25499","article-title":"The many faces of alpha-synuclein mutations","volume":"28","author":"Kasten","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2026.106186_bib40","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1007\/s12035-024-04469-x","article-title":"Role of mitochondrial dysfunctions in neurodegenerative disorders: advances in mitochondrial biology","volume":"62","author":"Kathiresan","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2026.106186_bib41","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106186_bib42","doi-asserted-by":"crossref","first-page":"9197","DOI":"10.3390\/ijms25179197","article-title":"The role of \u03b1-synuclein in etiology of neurodegenerative diseases","volume":"25","author":"Krawczuk","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2026.106186_bib43","doi-asserted-by":"crossref","first-page":"99.e1","DOI":"10.1016\/j.neurobiolaging.2020.08.015","article-title":"Mutation analysis of LRP10 in a large Chinese familial Parkinson disease cohort","volume":"99","author":"Li","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2026.106186_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2023.107122","article-title":"The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease","volume":"303","author":"Li","year":"2023","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.neuint.2026.106186_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroscience.2024.10.033","article-title":"Neuroglobin protects dopaminergic neurons in a Parkinson's cell model by interacting with mitochondrial complex NDUFA10","volume":"562","author":"Liang","year":"2024","journal-title":"Neurosci"},{"key":"10.1016\/j.neuint.2026.106186_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00018-024-05135-0","article-title":"LRP10 and \u03b1-synuclein transmission in Lewy body diseases","volume":"81","author":"Mascaro","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2026.106186_bib47","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mcn.2011.11.006","article-title":"Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression","volume":"49","author":"McLean","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2026.106186_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12964-023-01402-y","article-title":"The involvement of \u03b1-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease","volume":"22","author":"Miao","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.neuint.2026.106186_bib49","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.yjmcc.2009.10.026","article-title":"ER stress in cardiovascular disease","volume":"48","author":"Minamino","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.neuint.2026.106186_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JPD-230183","article-title":"Defining a Lewy body: running up the hill of shifting definitions and evolving concepts","volume":"14","author":"Moors","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuint.2026.106186_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2026.106186_bib52","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","article-title":"Mechanisms of autophagy-lysosome dysfunction in neurodegenerative disease","volume":"25","author":"Nixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.neuint.2026.106186_bib53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41582-025-01163-x","article-title":"Characteristics and mechanisms of cognitive impairment in Parkinson disease","volume":"22","author":"Oikonomou","year":"2026","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuint.2026.106186_bib54","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1007\/s12035-016-9989-9","article-title":"Expression of the Parkinson's disease-associated gene alpha-synuclein is regulated by the neuronal cell fate determinant TRIM32","volume":"54","author":"Pavlou","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2026.106186_bib55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fnins.2018.00199","article-title":"Advancing stem cell models of alpha-synuclein gene regulation in neurodegenerative disease","volume":"12","author":"Piper","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2026.106186_bib56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnmol.2017.00054","article-title":"Functional roles of the interaction of APP and lipoprotein receptors","volume":"10","author":"Pohlkamp","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2026.106186_bib57","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(18)30179-0","article-title":"LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study","volume":"17","author":"Quadri","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2026.106186_bib58","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/ejn.16136","article-title":"Dopaminergic neuronal death via necroptosis in Parkinson's disease: a review of the literature\u201d","volume":"59","author":"Regoni","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106186_bib59","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson's disease: what we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2026.106186_bib60","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4049\/jimmunol.2100035","article-title":"Microglial NLRP3 inflammasome activation upon TLR2 and TLR5 ligation by distinct \u03b1-synuclein assemblies","volume":"207","author":"Scheiblich","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuint.2026.106186_bib61","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1007\/s12035-024-03974-3","article-title":"The alpha-synuclein gene (SNCA) is a genomic target of methyl-CpG binding protein 2 (MeCP2)-implications for Parkinson's disease and Rett syndrome","volume":"61","author":"Schmitt","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2026.106186_bib62","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s12035-021-02596-3","article-title":"An update on the critical role of \u03b1-synuclein in Parkinson's disease and other synucleinopathies: from tissue to cellular and molecular levels","volume":"59","author":"Serratos","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2026.106186_bib63","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1007\/s12035-023-03830-w","article-title":"SIRT3-mediated deacetylation of SDHA rescues mitochondrial bioenergetics contributing to neuroprotection in rotenone-induced PD models","volume":"61","author":"Shen","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2026.106186_bib64","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.tins.2023.07.009","article-title":"Inflammasome assembly in neurodegenerative diseases","volume":"46","author":"Singh","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2026.106186_bib65","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/pharmaceutics15082051","article-title":"Inhibition of protein aggregation and endoplasmic reticulum stress as a targeted therapy for \u03b1-synucleinopathy","volume":"15","author":"Siwecka","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuint.2026.106186_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.167992","article-title":"Common mechanisms underlying \u03b1-synuclein-induced mitochondrial dysfunction in Parkinson's disease","volume":"435","author":"Sohrabi","year":"2023","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuint.2026.106186_bib67","doi-asserted-by":"crossref","first-page":"15817","DOI":"10.1021\/bi001583s","article-title":"A novel low-density lipoprotein receptor-related protein mediating cellular uptake of apolipoprotein E-enriched beta-VLDL in vitro","volume":"39","author":"Sugiyama","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2026.106186_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.947191","article-title":"The relationship of alpha-synuclein to mitochondrial dynamics and quality control","volume":"15","author":"Thorne","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2026.106186_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.822949","article-title":"Monogenetic forms of Parkinson's disease-bridging the gap between genetics and biomarkers","volume":"14","author":"T\u00f6nges","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2026.106186_bib70","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202409104","article-title":"Synaptic sabotage: how tau and \u03b1-synuclein undermine synaptic health","volume":"224","author":"Uytterhoeven","year":"2025","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuint.2026.106186_bib72","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41418-019-0368-8","article-title":"CCAAT\/enhancer binding protein \u03b4 is a transcriptional repressor of \u03b1-synuclein","volume":"27","author":"Valente","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuint.2026.106186_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.parkreldis.2019.05.037","article-title":"LRP10 variants in Parkinson's disease and dementia with lewy bodies in the South-West of the Netherlands","volume":"65","author":"Vergouw","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuint.2026.106186_bib71","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","article-title":"Parkinson's disease genetics and pathophysiology","volume":"44","author":"V\u00e1zquez-V\u00e9lez","year":"2021","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2026.106186_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1288894","article-title":"Strategies targeting endoplasmic reticulum stress to improve Parkinson's disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106186_bib75","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fnagi.2019.00316","article-title":"Catalpol exerts a neuroprotective effect in the MPTP mouse model of Parkinson's disease","volume":"11","author":"Wang","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuint.2026.106186_bib76","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/cells11132091","article-title":"Microglia phenotypes in aging and neurodegenerative diseases","volume":"11","author":"Wendimu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuint.2026.106186_bib77","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41380-020-0687-7","article-title":"C\/EBP\u03b2\/\u03b4-secretase signaling mediates Parkinson's disease pathogenesis via regulating transcription and proteolytic cleavage of \u03b1-synuclein and MAOB","volume":"26","author":"Wu","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuint.2026.106186_bib78","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.1073\/pnas.181182298","article-title":"Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease","volume":"98","author":"Xia","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2026.106186_bib79","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1007\/s12035-024-03981-4","article-title":"Ripks and neuroinflammation","volume":"61","author":"Xu","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2026.106186_bib80","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2026.106186_bib81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","article-title":"Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases","volume":"20","author":"Yuan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2026.106186_bib82","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.apsb.2021.02.016","article-title":"Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.neuint.2026.106186_bib83","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13578-024-01256-y","article-title":"Role of NLRP3 inflammasome in central nervous system diseases","volume":"14","author":"Zhang","year":"2024","journal-title":"Cell Biosci."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019701862600077X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019701862600077X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:31:58Z","timestamp":1783121518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019701862600077X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":83,"alternative-id":["S019701862600077X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106186","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lrp10 insufficiency upregulates mRNA and protein of neurotoxic \u03b1-synuclein and causes degeneration of substantia nigra dopaminergic neurons in heterozygous or homozygous Lrp10 knockout mice","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106186"}}